药理学
医学
阿托品
药品管理局
呼吸道
重症监护医学
麻醉
呼吸系统
内科学
作者
Ahmed S. Abo Dena,Alaa M. Ali,Ibrahim M. El‐Sherbiny
出处
期刊:Profiles of Drug Substances, Excipients and Related Methodology
日期:2020-01-01
卷期号:: 41-53
标识
DOI:10.1016/bs.podrm.2019.10.002
摘要
Carbetapentane citrate, a non-opioid centrally-acting antitussive drug, is a common treatment for cough associated with other diseases such as common cold and respiratory tract infections. Its mode of action is very close to that of atropine; since it acts at the level of the peripheral parasympathetic nerve endings. The drug reaches its maximum plasma concentration (Cmax) 2h after administration, and it has a plasma half-life of 2.3h in case of oral administration. Due to its clinical importance, there are many analytical methods in the literature for carbetapentane determination. In addition, it is crucial to collect its analytical results in a single chapter so as to allow researchers to easily interpret their experimental data. Here, we provide the analytical profile of carbetapentane citrate with a brief description/interpretation of each analysis.
科研通智能强力驱动
Strongly Powered by AbleSci AI